Provention Bio, Inc. - Common Stock (NQ:PRVB)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Provention Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

The Law Offices of Frank R. Cruz Announces Investigation of Provention Bio, Inc. (PRVB) on Behalf of Investors

May 27, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

SHAREHOLDER ALERT: Robbins LLP Announces that Provention Bio, Inc. (PRVB) is Being Sued for Misleading Shareholders

May 27, 2021

From Robbins LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Provention Bio, Inc. (PRVB) Investors

May 27, 2021

From Law Offices of Howard G. Smith

Via Business Wire

Earnings Scheduled For May 6, 2021 ↗

May 06, 2021

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...

Via Benzinga

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 27, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 26, 2021

Gainers Owens & Minor (NYSE:OMI) shares rose 25.47% to $40.66 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 5.4...

Via Benzinga

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Provention Bio, Inc. (PRVB) on Behalf of Investors

May 26, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 26, 2021

From The Schall Law Firm

Via Business Wire

54 Biggest Movers From Yesterday ↗

May 26, 2021

Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...

Via Benzinga

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Provention Bio, Inc. (PRVB) on Behalf of Investors

May 25, 2021

From Law Offices of Howard G. Smith

Via Business Wire

Mid-Afternoon Market Update: Dycom Industries Drops Following Q1 Results; The Joint Corp Shares Slide ↗

May 25, 2021

Toward the end of trading Tuesday, the Dow traded down 0.09% to 34,362.49 while the NASDAQ fell 0.04% to 13,655.88. The S&P also fell, dropping 0.14% to 4,191.36. The U.S. has...

Via Benzinga

Topics Stocks

Why Provention Bio Stock Is Trading Higher Today? ↗

May 25, 2021

The FDA published Provention Bio Inc’s (NASDAQ: PRVB) teplizumab-related briefing documents ahead of an Advisory Committee meeting scheduled for May 27...

Via Benzinga

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 25, 2021

From The Schall Law Firm

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 25, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 43.23% to $2.65 during Tuesday's regular session. As of 12:30 EST, Pieris Pharmaceuticals's...

Via Benzinga

Mid-Day Market Update: US Stocks Turn Lower; Provention Bio Shares Surge ↗

May 25, 2021

Midway through trading Tuesday, the Dow traded down 0.16% to 34,337.29 while the NASDAQ fell 0.16% to 13,638.63. The S&P also fell, dropping 0.20% to 4,188.77. The U.S. has...

Via Benzinga

Topics Stocks

42 Stocks Moving In Tuesday's Mid-Day Session ↗

May 25, 2021

Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's...

Via Benzinga

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Provention Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline – PRVB

May 25, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

Why Provention Bio Stock Is Soaring Today ↗

May 25, 2021

The FDA posted briefing documents that appear to bode well for approval of the company's lead candidate.

Via The Motley Fool

Mid-Morning Market Update: Markets Edge Higher; AutoZone Tops Q3 Expectations ↗

May 25, 2021

Following the market opening Tuesday, the Dow traded up 0.06% to 34,413.00 while the NASDAQ rose 0.15% to 13,681.64. The S&P also rose, gaining 0.10% to 4,201.32. The U.S. has...

Via Benzinga

Topics Stocks

PROVENTION ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Provention Bio, Inc. and Encourages Investors to Contact the Firm

May 24, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation ↗

May 23, 2021

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.

Via Talk Markets

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation ↗

May 23, 2021

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts....

Via Benzinga

Notice of Lead Plaintiff Deadline for Shareholders in the Provention Bio, Inc. Class Action Lawsuit

May 21, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

May 11, 2021

Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

Provention Bio, Inc (PRVB) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

PRVB earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Apr. 28, 2021: AMD, PRVB, AAPL, FB, MVIS ↗

April 28, 2021

Today's 5 Stock Ideas: Advanced Micro Devices (AMD) - Shares were trading roughly 4.40% higher Wednesday morning following better-than-expected Q1 EPS and sales...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.